Is compounded semaglutide safe? What to know before you start
Compounded semaglutide is not FDA-approved, so no compounded version has been reviewed by FDA for safety, effectiveness or quality before it is dispensed. That does not make every compounded product unsafe, but the protections that come with an approved medicine do not apply in the same way. Most of the risks you can control come down to three questions: who prepares it, what exactly is in the vial and how the dose is measured. FDA on compounded drugs.
What is compounded semaglutide?
Compounding is when a pharmacy prepares a medicine for an individual patient based on a prescription. Semaglutide is a GLP-1 receptor agonist: it acts like a hormone the body releases after eating, which affects appetite, how quickly the stomach empties and blood sugar. Semaglutide injection information.
FDA-approved semaglutide medicines include Ozempic, approved for type 2 diabetes, and Wegovy, approved for chronic weight management. Compounded semaglutide is a separate product prepared by a compounding pharmacy. It is not a generic version of either medicine, and FDA has warned companies not to describe compounded drugs as generic or as the same as an approved drug. FDA guidance for telehealth companies.
How is it different from Ozempic and Wegovy?
| Ozempic and Wegovy injections | Compounded semaglutide | |
|---|---|---|
| FDA review before sale | Yes: safety, effectiveness and manufacturing quality | No |
| Clinical trials of the product itself | Yes | No published trials of compounded formulations |
| Usual form | Prefilled pen with set doses | Often a multi-dose vial drawn up with a syringe |
| Ingredients | Approved formula | Set by the pharmacy; may include an added ingredient such as glycine, niacinamide or a vitamin |
| Who makes it | Manufacturer, under the FDA approval | State-licensed compounding pharmacy or registered outsourcing facility |
The form matters in practice. With a pen, the dose is set by the device. With a vial, you measure each dose yourself, which is where FDA has seen serious errors.
Do Wegovy results apply to compounded semaglutide?
No. The STEP clinical trials that support Wegovy’s approval tested Wegovy itself, at specific doses, together with diet and exercise. Those results describe that product. No comparable trials have been published for compounded semaglutide, so its results cannot be assumed to match. STEP 1 trial.
What does FDA warn about?
FDA keeps a public page on unapproved GLP-1 drugs, last updated October 1, 2026. The main concerns are: FDA concerns with unapproved GLP-1 drugs.
- Adverse event reports. As of May 31, 2026, FDA had received 990 reports of adverse events associated with compounded semaglutide. A report shows that a problem was reported, not that the medicine caused it.
- Dosing errors. FDA has described patients who injected 5 to 20 times the intended dose after confusing milliliters, milligrams and syringe “units”. Some needed hospital care. FDA dosing error alert.
- Salt forms. Semaglutide sodium and semaglutide acetate are different active ingredients from the one used in the approved medicines. FDA says it knows of no lawful basis for compounding with them.
- Fake products. FDA has found counterfeit Ozempic and sellers that operate without a prescription or a state license.
- Opened vials. FDA advises discarding a multi-dose vial within 28 days after first use, even if medicine remains or the label allows longer.
Is compounded semaglutide still legal?
The semaglutide injection shortage ended on February 21, 2025, and the temporary flexibility FDA allowed during the shortage has ended. Compounding is still allowed under conditions, but pharmacies generally may not regularly make copies of an approved drug. One exception is when a prescriber documents that a change produces a significant difference for an identified patient. Lower price or an added vitamin does not qualify by itself. Our guide to GLP-1 compounding rules after the shortages explains the details.
What should you check before starting?
- A real evaluation. A licensed provider should review your health history, current medicines and goals before prescribing.
- The pharmacy. The label should name a state-licensed pharmacy. Avoid any seller that offers semaglutide without a prescription.
- The ingredients. Confirm the active ingredient and everything else in the vial. If the label lists semaglutide sodium or semaglutide acetate, contact your provider and pharmacist before using it.
- The dose in writing. Your instructions should state the dose in milligrams and the exact amount to draw in milliliters or syringe units. Use the syringes supplied with your prescription and ask for help before your first injection if anything is unclear.
- Storage and dates. Check the beyond-use date, storage temperature and how long an opened vial can be used.
- Who to call. Know how to reach the provider and the pharmacy if you have side effects or questions.
Side effects and when to get help
The most common side effects are digestive: nausea, vomiting, diarrhea, constipation and stomach pain, especially after starting or raising the dose. Get medical help right away for severe stomach pain that does not go away, signs of an allergic reaction, or a lump or swelling in the neck. Approved semaglutide products carry a boxed warning about thyroid C-cell tumors, so tell your provider if you or a family member has had medullary thyroid cancer or MEN 2. Semaglutide side effects.
You can report a side effect to FDA through MedWatch.
How compounded semaglutide works at US Quick Health
US Quick Health offers compounded semaglutide, so this guide is published by a telehealth platform with a commercial interest in arranging access to it. A licensed U.S. provider reviews your online consultation. If treatment is appropriate, the provider chooses the formulation, with glycine or niacinamide, and the dose. A licensed U.S. compounding pharmacy prepares the medicine and ships it with syringes, alcohol swabs and instructions. The consultation is included in the price, and if a prescription is not written, you get a full refund. The service is not available in West Virginia, Kansas, New Mexico, Louisiana or Mississippi.
If you would rather use an FDA-approved medicine, Wegovy and Ozempic are also available through the same consultation. For the tirzepatide version of this guide, see is compounded tirzepatide safe.
Medically reviewed by
Hasan Igde - MD
Clinical Expertise: Anesthesiology, Emergency Medicine, Urology, and Oncology
Dr. Igde reviewed the medical information on this page for accuracy against current medical knowledge. This is an editorial, non-clinical review: it is not medical advice and does not create a doctor-patient relationship. Whether a treatment is appropriate for you is decided by an independent U.S. licensed provider.
For more information about the scope of the reviewed content and the role of our medical advisors, please visit our Medical Board page.

Compounded semaglutide FAQ
Is compounded semaglutide FDA-approved?
No. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are marketed. FDA-approved semaglutide medicines include Ozempic and Wegovy.
Is compounded semaglutide a generic Ozempic or Wegovy?
No. A generic drug is reviewed by FDA and shown to be the same as the brand-name medicine. A compounded drug is prepared by a pharmacy for an individual patient and is not reviewed that way, so it is not a generic version of, and not the same as, Ozempic or Wegovy.
Does glycine or niacinamide make compounded semaglutide work better?
There is no evidence that adding glycine, niacinamide or a vitamin makes compounded semaglutide safer or more effective. These ingredients are part of how a particular formulation is prepared. Ask your provider why a specific formulation was chosen for you.
Do Wegovy clinical trial results apply to compounded semaglutide?
No. The STEP trials studied Wegovy, an FDA-approved product. No comparable trials have been published for compounded semaglutide formulations, so the Wegovy results cannot be used to predict how a compounded product will work.
How long can I use a vial after opening it?
Discard an opened multi-dose vial of a compounded GLP-1 no later than 28 days after first use, even if medicine remains or the label allows longer, as FDA advises. Follow an earlier discard date if your label gives one, and ask your pharmacist about any conflicting instructions before injecting.
What should I do if my shipment arrives warm or damaged?
Do not inject it. Keep the package, contact the pharmacy or the service that arranged your prescription and ask whether the medicine can still be used or must be replaced.
Related guides
- Foundayo vs Wegovy pillFoundayo (orforglipron) vs the Wegovy pill (semaglutide): weight loss in trials, how to take each, doses, side effects and price. Facts from the FDA labels.
- How much does compounded semaglutide cost?What compounded semaglutide and tirzepatide cost at US Quick Health, what the price includes and how it compares with Wegovy, Zepbound and self-pay programs.
- Is compounded semaglutide still legal?The semaglutide and tirzepatide shortages are over. See what changed for compounding pharmacies, what a significant difference means and what patients should check.
- Is compounded tirzepatide safe?Compounded tirzepatide is not FDA-approved. See how it differs from Zepbound and Mounjaro, what FDA warns about and what to confirm before treatment.
- All health guides